Skip to content

The effects of omega-3 fatty acid (docosahexaenoic acid) supplementation on cognitive performance in healthy adults.

Effects of a high docosahexaenoic acid (DHA) fatty acid supplement on cognitive performance in healthy adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000212055
Enrollment
200
Registered
2010-03-16
Start date
2010-03-30
Completion date
2010-05-04
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To investigate whether a high DHA fatty acid supplement will improve cognitive performance tasks in 200 healthy adults over a period of 6 months using a randomised placebo controlled double blind study design.

Interventions

3 capsules per day for 6 months to be consumed orally of docosahexaenoic fatty acid supplement (providing 1.124 mg of docosahexaenoic acid/day)

Sponsors

Massey University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy men and women 18-45 years

Exclusion criteria

High habitual intake of fatty fish (>1 serving/month) Consuming fish oil supplements Smokers Allergies to seafood Pregnant or lactating

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 24, 2026